4-(3-Nitrophenyl)-1,2,3,6-tetrahydropyridine hydrochloride, 97%, 1g

4-amino-5-pyrimidinecarboxamide, 95.0%, 1g

7,7-Difluorotetrahydropyrrolo[1,2-a]pyrazine-1,3(2H,4H)-dione, 95.0%, 25mg

2,6-Bis((R)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)pyridine, 98.0%, 50mg

4-Bromo-2-methoxy-6-methylpyridine, 95.0%, 5g

tert-Butyl (3-methyl-2-nitrophenyl)carbamate, 95.0%, 100mg

2-METHOXY-N-(PROP-2-YNYL)ACETAMIDE, 95.0%, 1g

trans-1,4-Cyclohexanedicarboxylic Acid>97.0%(GC)(T)500g

7H-Dibenzo[c,g]carbazole, 95.0%, 25g

5-Acetyl-2-chlorophenylboronic acid, 95.0%, 250mg

(E)-N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N6-(N,N'-diethylcarbamimidoyl)-L-lysine hydrochloride, 98%, 25g

(S)-tert-Butyl 2-amino-3-(4-(tert-butoxy)phenyl)propanoate hydrochloride, 95.0%, 5g

Pipetta per microlitri a canale singolo Pipetman® G, da 0,2 a 2 µl, P2G, 1 pezzo